Biblio
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics. Br J Haematol. 2022.
Circulating Tumor DNA in Lymphoma: Principles and Future Directions. Blood Cancer Discov. 2022;3(1):5-15.
. Assessment of the 4-factor score: retrospective analysis of 586 cll patients receiving ibrutinib. A campus cll study. Am J Hematol. 2021.
Clinical implications of the molecular genetics of chronic lymphocytic leukemia. Haematologica. 2013;98(5):675-85.
.